Tags: Judge | Award | Lilly | Takeda

Judge Slashes $9 Billion Award against Lilly, Takeda

Monday, 27 Oct 2014 05:55 PM

A U.S. judge on Monday slashed a $9 billion punitive damages award to $36.8 million against Takeda Pharmaceutical Co. and Eli Lilly & Co. over their Actos diabetes drug.

U.S. District Judge Rebecca Doherty in Louisiana in a court filing granted a motion from the drugmakers to reduce the $9 billion in combined punitive damages awarded earlier this year.

In the first federal case to go to trial in a consolidated group of lawsuits, the companies were accused of failing to warn users that Actos could raise the risk for bladder cancer.

In her ruling, Doherty said the original $9 billion damages award was "excessive" and violated the companies' constitutional rights to due process.

She ordered Takeda to pay $27.6 million and Eli Lilly to pay $9.2 million for a total of $36.8 million.

She rejected a request by both companies for a new trial.

Actos, an oral medication used to regulate blood sugar levels in patients with type-2 diabetes, has been on the market since 1999. Lilly, which co-promoted Actos from 1999 to 2006, has said it will be indemnified by Takeda for its losses and litigation expenses under their agreement.

The case, brought by plaintiff Terrence Allen, is among more than 3,700 that were consolidated before Doherty in Louisiana. The companies face additional lawsuits in state courts.

The jury had also awarded Allen $1.475 million in compensatory damages, which was later reduced to $1.27 million.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Companies
A U.S. judge on Monday slashed a $9 billion punitive damages award to $36.8 million against Takeda Pharmaceutical and Eli Lilly over their Actos diabetes drug.
Judge, Award, Lilly, Takeda
237
2014-55-27
Monday, 27 Oct 2014 05:55 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved